Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Acrux ( (AU:ACR) ) has provided an announcement.
Acrux Limited announced the results of its Annual General Meeting held on November 25, 2025, where all resolutions were passed, including a special resolution for a 10% placement capacity. This outcome reflects strong shareholder support and positions Acrux to potentially expand its market presence and operational capabilities.
More about Acrux
Acrux (ASX: ACR) is a pharmaceutical company specializing in the development and commercialization of topical pharmaceuticals. With 25 years of experience, the company has successfully launched several topically applied pharmaceutical products in the US and Europe through licensees.
Average Trading Volume: 350,812
Technical Sentiment Signal: Sell
Current Market Cap: A$6.55M
See more insights into ACR stock on TipRanks’ Stock Analysis page.